Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Deferred Revenue

₹1.74B

Quarterly · Period ending: · INR

RDY logo

RDY Deferred Revenue

Latest reported₹1.74B INR
RDY Quarterly Deferred Revenue · INR (₹450.63M → ₹1.74B)
High-resolution chart · PNG

RDY deferred revenue history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Deferred Revenue — Quarterly (INR)
Period endingDeferred Revenue (INR)
1,744,000,000
0
1,780,000,000
2,065,000,000
1,834,000,000
1,983,000,000
1,997,000,000
1,530,000,000
0
1,435,000,000
27,267,128
3,001,000,000
0
1,981,000,000
0
0
0
33,995,381
0
0
0
27,805,987
0
0
0
25,247,434
0
4,789,000,000
4,629,000,000
1,351,000,000
4,734,000,000
4,989,000,000
4,505,000,000
982,000,000
5,432,000,000
5,529,000,000
5,888,000,000
819,000,000
7,117,000,000
6,752,000,000
6,547,000,000
659,000,000
7,689,000,000
7,711,000,000
6,598,000,000
1,056,000,000
5,719,000,000
4,948,000,000
4,248,000,000
678,000,000
4,340,000,000
3,780,000,000
3,624,000,000
553,000,000
3,425,000,000
3,233,000,000
3,214,000,000
2,607,000,000
3,280,000,000
1,935,000,000
75,000,000
503,000,000
2,854,000,000
1,622,000,000
34,000,000
2,526,000,000
2,527,000,000
2,480,000,000
32,000,000
1,928,000,000
1,819,000,000
1,468,501,000
1,193,611,000
4,155,240,000
461,014,000
477,449,000
737,908,000
3,967,900,548
1,307,284,000
913,157,000
351,097,000
3,091,079,334
189,904,000
277,926,000
225,776,000
2,375,065,378
111,721,000
169,705,000
216,249,000
1,246,767,955
64,097,000
111,041,000
831,116,316
166,510,000,000
297,598,000
0
0
695,285,705
564,963,842
432,838,204
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.